INDEPENDENT NEWS

Meningitis Foundation Calls For Funding Of Vaccines To Be Included In Pharmac Funding Boost

Published: Fri 21 Jun 2024 03:57 PM
The Meningitis Foundation Aotearoa New Zealand says reports that the Government plans to inject an additional $600 million towards Pharmac-funded medicines “can’t come soon enough”.
It is reported that the Government is planning increase Pharmac funding by approximately 40%, which will be directed towards cancer drugs, while also allowing Pharmac to purchase medications and vaccines for other illnesses.
Meningitis Foundation chair, Gerard Rushton, says the Foundation welcomes the additional funding, which will bring Aotearoa New Zealand back in line with medicines funding for other OCED nations, which spend 1.4% of GDP on average on publicly financed pharmaceutical spending (New Zealand’s spend is 0.45%). He stresses that a portion of the funding must be directed towards vaccination against meningitis.
“We know Pharmac is seeking to fund wider immunisation against meningococcal meningitis, and the reported funding boost gives them the opportunity to do so.” There were 13 cases of meningococcal meningitis in the year to June, and each of those could have easily proven fatal,” says Gerard Rushton
Pharmac’s Immunisation Advisory Committee has also recommended with a medium priority that eligibility for meningococcal ACWY conjugate vaccine for people aged 13-25 years be widened to those who are eligible for Community Services Cards, as well as their dependants.
With 718,209 Community Services Cards currently on issue and reissued, that could see up to 700,000 additional households become eligible for vaccination, including 200,000 Māori and 80,000 Pasifika households.
Gerard Rushton says the organisation is calling on the Government to make access to both meningococcal vaccines, as well as the pneumococcal vaccine, free for all young people under the age of 25.
“We need to vaccinate across the board to best protect our rangatahi,” says Gerard. “The current approach is patchy at best, the eligibility criteria are confusing, and the current approach is ultimately ineffective.”
The symptoms of meningococcal meningitis in adults and children are:A stiff, sore neck.A sensitivity to light, or a dislike of bright lights (an early warning sign of meningitis).A severe headache.If the child or adult is difficult to wake, or in a drowsy and confused state.A fever, sometimes accompanied by cold hands and feet.Aching sore joints.Vomiting – a common symptom of meningitis in both children and adults.Convulsive fits or seizures is characteristic of meningitis

Next in Lifestyle

Well-Meaning Tourists Pose A Threat To Kea, Study Shows
By: University of Canterbury
‘Yearning For A Spoon’ - The Late Poems Of JH Prynne
By: Howard Davis
‘Quite Emotional’: Thousands Crowd At Rotorua Lake Edge To Watch Matariki Show
By: Laura Smith - Local Democracy Reporter
Addressing The Hormone Replacement Therapy (HRT) Crisis Amid Global Shortages
By: MyMT
Extra $600m To Fund Cancer Meds And Other Treatments – Expert Reaction
By: Science Media Centre
Record Running In Wellington Today
By: Wellington Marathon
View as: DESKTOP | MOBILE © Scoop Media